Can a 10-Week stress program improve life for prostate cancer patients?

NCT ID NCT03344757

Symptom relief Sponsor: University of Miami Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a 10-week stress management group program for Spanish-speaking Hispanic men who had treatment for prostate cancer. The program taught relaxation, coping skills, and ways to handle stress. Researchers measured changes in quality of life, mood, and physical symptoms. The goal was to see if this culturally adapted approach could help men feel better overall.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: Culturally adapted cognitive behavioral stress management program
What this could lead to: If successful, this program could offer a practical way to help Hispanic men with prostate cancer feel better emotionally and physically.
What could go wrong: This is a small, completed study without a control group, so results may not apply to all patients. The program requires in-person attendance, which may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

188 people

The number who actually took part.

Started

Oct 2017

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. ≥ 18 years of age; 2. Hispanic/Latino self-identification; 3. Spanish speakers (including bilinguals who express interest in a Spanish-based psychosocial intervention); 4. Primary diagnosis of localized Prostate Cancer (T1-T3, N0, M0); 5. Surgical or radiation treatment (e.g., external beam, brachytherapy, proton) within minimum of 4 months and maximum of 72-months; 6. Some patients with prior inpatient psychiatric treatment for severe mental illness or overt signs of severe psychopathology (e.g., psychosis) may be enrolled, per P.I. discretion, based on a case-by-case review; 7. Willingness to be randomized and followed for approximately12 months. Exclusion Criteria: 1. History of non-skin cancer within the last 2 years. 2. Prior inpatient psychiatric treatment for severe mental illness or overt signs of severe psychopathology (e.g., psychosis) within the past six months, as these conditions can interfere with adequate participation in our experimental conditions may be exclusionary, per P.I. discretion, based on a case-by-case review; 3. Active alcohol dependence within the past six months may be exclusionary, per P.I. discretion, based on a case-by-case review; 4. Active substance dependence within the past six months may be exclusionary, per P.I. discretion, based on a case-by-case review; and 5. Acute or chronic immune system medical conditions, medications or conditions that impact immune and endocrine function (e.g., Chronic Fatigue Syndrome (CFS), Lupus, rheumatoid arthritis, Hepatitis C, or immunosuppressive treatment requiring conditions), per PI discretion based on a case by case review. 6. Individuals scoring \>3 on the SPMSQ will be excluded or per PI discretion based on a case by case review. .

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Genital diseases, male are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

male reproductive organ cancer male reproductive system disorder prostate cancer prostate carcinoma prostate disorder prostate neoplasm Urogenital Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Genital diseases, male Genital neoplasms, male Neoplasm, prostate Prostate neoplasm Prostatic diseases Urogenital neoplasms

Can a 10-Week stress program improve life for prostate cancer patients?

What the study statuses mean